Jain, R. Ok. & Stylianopoulos, T. Delivering nanomedicine to strong tumors. Nat. Rev. Clin. Oncol. 7, 653–664 (2010).
Zhang, Z. et al. Rational design of nanoparticles with deep tumor penetration for efficient therapy of tumor metastasis. Adv. Funct. Mater. 28, 1801840 (2018).
Souri, M., Soltani, M., Moradi Kashkooli, F. & Kiani Shahvandi, M. Engineered methods to boost tumor penetration of drug-loaded nanoparticles. J. Management. Launch 341, 227–246 (2022).
Wong, C. et al. Multistage nanoparticle supply system for deep penetration into tumor tissue. Proc. Natl Acad. Sci. USA 108, 2426–2431 (2011).
Zhou, Q. et al. Enzyme-activatable polymer-drug conjugate augments tumour penetration and therapy efficacy. Nat. Nanotechnol. 14, 799–809 (2019).
Wang, G. W. et al. Enzyme-triggered transcytosis of dendrimer-drug conjugate for deep penetration into pancreatic tumors. ACS Nano 14, 4890–4904 (2020).
Liu, Y. et al. Transcytosis of nanomedicine for tumor penetration. Nano Lett. 19, 8010–8020 (2019).
Blanco, E., Shen, H. & Ferrari, M. Ideas of nanoparticle design for overcoming organic obstacles to drug supply. Nat. Biotechnol. 33, 941–951 (2015).
Mitchell, M. J. et al. Engineering precision nanoparticles for drug supply. Nat. Rev. Drug Discov. 20, 101–124 (2021).
Chen, L. et al. Dimension and cost dual-transformable mesoporous nanoassemblies for enhanced drug supply and tumor penetration. Chem. Sci. 11, 2819–2827 (2020).
Dai, L. L. et al. Dimension/cost changeable acidity-responsive micelleplex for photodynamic-improved PD-L1 immunotherapy with enhanced tumor penetration. Adv. Funct. Mater. 28, 1707249 (2018).
Zhen, J. R. et al. Nanocarriers aware of a hypoxia gradient facilitate enhanced tumor penetration and improved anti-tumor efficacy. Biomater. Sci. 7, 2986–2995 (2019).
Zhang, H., Kong, X., Tang, Y. & Lin, W. Hydrogen sulfide triggered charge-reversal micelles for cancer-targeted drug supply and imaging. ACS Appl. Mater. Interfaces 8, 16227–16239 (2016).
Li, Y., Yang, H. Y., Thambi, T., Park, J. H. & Lee, D. S. Cost-convertible polymers for improved tumor focusing on and enhanced remedy. Biomaterials 217, 119299 (2019).
Mi, P. Stimuli-responsive nanocarriers for drug supply, tumor imaging, remedy and theranostics. Theranostics 10, 4557–4588 (2020).
Paschke, S. et al. Are colon and rectal most cancers two completely different tumor entities? A proposal to desert the time period colorectal most cancers. Int. J. Mol. Sci. 19, 2577 (2018).
Rawla, P., Sunkara, T. & Barsouk, A. Epidemiology of colorectal most cancers: incidence, mortality, survival, and threat components. Prz. Gastroenterol. 14, 89–103 (2019).
Sato, S., Kato, T. & Tanaka, J. I. Defining the distal margin of rectal most cancers for surgical planning. J. Gastrointest. Oncol. 8, 194–198 (2017).
Rubinkiewicz, M. et al. A quest for sphincter-saving surgical procedure in ultralow rectal tumours—a single-centre cohort examine. World J. Surg. Oncol. 16, 218 (2018).
Scheele, J. et al. High quality of life after sphincter-preserving rectal most cancers resection. Clin. Colorectal Most cancers 14, e33–e40 (2015).
Chiang, J. M. et al. Rectal most cancers stage considerably impacts charges and patterns of distant metastases amongst rectal most cancers sufferers submit curative-intent surgical procedure with out neoadjuvant remedy. World J. Surg. Oncol. 12, 197 (2014).
Bruheim, Ok. et al. Sexual perform in females after radiotherapy for rectal most cancers. Acta Oncol. 49, 826–832 (2010).
Choi, S. H. et al. Diminished pelvic area sparing anastomosis for postoperative radiotherapy in chosen sufferers with mid-upper rectal most cancers. J. Radiat. Res. 58, 559–566 (2017).
Bruheim, Ok. et al. Late unwanted effects and high quality of life after radiotherapy for rectal most cancers. Int. J. Radiat. Oncol. Biol. Phys. 76, 1005–1011 (2010).
Li, X., Lovell, J. F., Yoon, J. & Chen, X. Medical improvement and potential of photothermal and photodynamic therapies for most cancers. Nat. Rev. Clin. Oncol. 17, 657–674 (2020).
Guidolin, Ok. et al. Photodynamic remedy for colorectal most cancers: a scientific evaluate of medical analysis. Surg. Innov. 29, 788–803 (2022).
Chen, L. et al. Progress of nanomaterials in photodynamic remedy in opposition to tumor. Entrance. Bioeng. Biotechnol. 10, 920162 (2022).
Alsaab, H. O. et al. Progress in medical trials of photodynamic remedy for strong tumors and the position of nanomedicine. Cancers 12, 2793 (2020).
Gu, L. et al. Enzyme-triggered deep tumor penetration of a dual-drug nanomedicine allows an enhanced most cancers mixture remedy. Bioact. Mater. 26, 102–115 (2023).
Lee, D. et al. Overcoming the obstacles of present photodynamic remedy in tumors utilizing nanoparticles. Bioact. Mater. 8, 20–34 (2022).
Baek, M.-J. et al. Tailoring renal-clearable zwitterionic cyclodextrin for colorectal cancer-selective drug supply. Nat. Nanotechnol. 18, 945–956 (2023).
Lei, Z., Zhang, X., Zheng, X., Liu, S. & Xie, Z. Porphyrin–ferrocene conjugates for photodynamic and chemodynamic remedy. Org. Biomol. Chem. 16, 8613–8619 (2018).
Tapia Hernandez, R., Lee, M. C., Yadav, A. Ok. & Chan, J. Repurposing cyanine photoinstability to develop near-infrared light-activatable nanogels for in vivo cargo supply. J. Am. Chem. Soc. 144, 18101–18108 (2022).
Facciotti, C. et al. Oxidant-responsive ferrocene-based cyclodextrin complicated coacervate coremicelles. Supramol. Chem. 32, 30–38 (2020).
Wan, Q. et al. Molecular engineering to spice up AIE-active free radical photogenerators and allow high-performance photodynamic remedy beneath hypoxia. Adv. Funct. Mater. 30, 2002507 (2020).
Meng, X. et al. Twin-responsive molecular probe for tumor focused imaging and photodynamic remedy. Theranostics 7, 1781–1794 (2017).
Fortunate, S. S., Soo, Ok. C. & Zhang, Y. Nanoparticles in photodynamic remedy. Chem. Rev. 4, 1990–2042 (2015).
Yu, Y. et al. Cationization to spice up each kind I and kind II ROS era for photodynamic remedy. Biomaterials 280, 121255 (2022).
Huang, L. et al. Gentle photothermal remedy potentiates anti-PD-L1 therapy for immunologically chilly tumors by way of an all-in-one and all-in-control technique. Nat. Commun. 10, 4871 (2019).
Deng, X., Shao, Z. & Zhao, Y. Options to the drawbacks of photothermal and photodynamic most cancers remedy. Adv. Sci. 8, 2002504 (2021).
Zhang, Z. J., Wang, Ok. P., Mo, J. G., Xiong, L. & Wen, Y. Photodynamic remedy regulates destiny of most cancers stem cells by reactive oxygen species. World J. Stem Cells 12, 562–584 (2020).
Forkasiewicz, A. et al. The usefulness of lactate dehydrogenase measurements in present oncological observe. Cell. Mol. Biol. Lett. 25, 35 (2020).
Ninomiya, I. et al. Anti-metastatic impact of capecitabine on human colon most cancers xenografts in nude mouse rectum. Int. J. Most cancers 112, 135–142 (2004).
Bolze, F., Jenni, S., Bitter, A. & Heitz, V. Molecular photosensitisers for two-photon photodynamic remedy. Chem. Commun. 53, 12857–12877 (2017).
Kasashima, H. et al. Mouse mannequin of colorectal most cancers: orthotopic co-implantation of tumor and stroma cells in cecum and rectum. STAR Protoc. 2, 100297 (2021).